Related Experiment Video
Updated: Jun 24, 2025

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis
Published on: November 10, 2023
Atypical BCR-ABL1 transcript in mixed phenotype acute leukemia with bone marrow necrosis
Jiarui Liu1, Yujie Jiang1, Dai Yuan1
1Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Philadelphia chromosome-positive (Ph+) mixed phenotype acute leukemia (MPAL) is rare. This case report details a patient with Ph+ MPAL and bone marrow necrosis, successfully treated with flumatinib and hyper-CVAD.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- Mixed phenotype acute leukemia (MPAL) presents mixed myeloid and lymphoid features.
- Philadelphia chromosome-positive (Ph+) MPAL is a rare, aggressive subtype with no established treatment consensus.
- Atypical BCR-ABL1 fusions are uncommon in Ph+ MPAL.
More Related Videos
07:39Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018